Inhibitor Therapeutics's total assets for Q3 2025 were $3.14M, a decrease of ― from the previous quarter. INTI total liabilities were $3.13M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.